Malassezia japonica isolated from the cerumen of Cercopithecidae and Hylobatidae.

IF 2.3 3区医学 Q3 INFECTIOUS DISEASES

Medical mycology Pub Date : 2025-09-02 DOI:10.1093/mmy/myaf078

Ryuri Tachikawa, Koshiro Watanuki, Yuta Shintaku, Dai Hirose

引用次数: 0

Abstract

Species diversity of Malassezia in the cerumen of nonhuman primates (NHPs) belonging to the Cercopithecidae and Hylobatidae families was investigated. Isolates from cerumen samples collected from carcasses were identified at the species level using 26S rRNA sequence analysis, and intraspecific genetic variation was evaluated using internal transcribed spacer sequences. Fifteen strains were isolated from 30 cerumen samples. They were all identified as Malassezia japonica and clustered into three phylogenetic groups. Malassezia japonica is not a dominant species on human skin, but the results obtained suggest its adaptation to the skin of NHPs.

查看原文本刊更多论文

从蠓科和蠓科耵聍中分离的日本马拉色菌。

研究了非人类灵长类（NHPs）耵聍中马拉色菌属（Malassezia）的物种多样性。采用26S rRNA序列分析方法在种水平上鉴定耳屎标本中的分离物，并利用内部转录间隔序列评估种内遗传变异。从30份耵聍标本中分离到15株。它们都被鉴定为日本马拉色菌，并聚为3个系统发育类群。粳稻不是人类皮肤上的优势种，但结果表明其对NHPs皮肤的适应性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical mycology 医学-兽医学

CiteScore

5.70

自引率

3.40%

发文量

632

审稿时长

12 months

期刊介绍： Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.